Global analysis of Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 3, Issue , 2013, Pages 8-19

  Ménard, Didier ^a   Andriantsoanirina, Valérie ^b   Khim, Nimol ^a   Ratsimbasoa, Arsène ^c   Witkowski, Benoit ^a   Benedet, Christophe ^a   Canier, Lydie ^a   Mercereau Puijalon, Odile ^d   Durand, Rémy ^b  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b AVICENNE HOSPITAL   (France)

^c Programme National de Lutte contre le Paludisme   (Madagascar)

^d CNRS   (France)

Author keywords

Genetic polymorphism; Malaria; Plasmodium falciparum; Quinine resistance

Indexed keywords

MOLECULAR MARKER; PLASMODIUM FALCIPARUM SODIUM PROTON EXCHANGE PROTEIN 1; QUININE; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; CONTROLLED STUDY; CULTURE TECHNIQUE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GEOGRAPHICAL VARIATION (SPECIES); IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; RELIABILITY; REVIEW; VALIDITY;

EID: 84871657242     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2012.10.001     Document Type: Review

References (55)

1. Achan J., Tibenderana J.K., Kyabayinze D., Wabwire Mangen F., Kamya M.R., Dorsey G., D'Alessandro U., Rosenthal P.J., Talisuna A.O. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ 2009, 339:b2763.
2. Adam I., Ali D.M., Noureldien W., Elbashir M.I. Quinine for the treatment of chloroquine-resistant Plasmodium falciparum malaria in pregnant and non-pregnant Sudanese women. Ann. Trop. Med. Parasitol. 2005, 99:427-429.
3. Adegnika A.A., Breitling L.P., Agnandji S.T., Chai S.K., Schutte D., Oyakhirome S., Schwarz N.G., Grobusch M.P., Missinou M.A., Ramharter M., Issifou S., Kremsner P.G. Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambarene, Gabon. Am. J. Trop. Med. Hyg. 2005, 73:263-266.
4. Anderson T.J., Nair S., Qin H., Singlam S., Brockman A., Paiphun L., Nosten F. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?. Antimicrob. Agents Chemother. 2005, 49:2180-2188.
5. + exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am. J. Trop. Med. Hyg. 2010, 82:782-787.
6. Andriantsoanirina, V., Khim, N., Ratsimbasoa, A., Witkowski, B., Benedet, C., Canier, L., Bouchier, C., Tichit, M., Durand, R., Ménard, D., 2012. Short report: Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) genetic polymorphism in Indian Ocean malaria endemic areas. Am. J. Trop. Med. Hyg. http://www.ajtmh.org/cgi/doi/10.4269/ajtmh.2012.12-0359.
7. Baird J.K. Effectiveness of antimalarial drugs. New Engl. J. Med. 2005, 352:1565-1577.
8. Baliraine F.N., Nsobya S.L., Achan J., Tibenderana J.K., Talisuna A.O., Greenhouse B., Rosenthal P.J. Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Antimicrob. Agents Chemother. 2010, 55:615-622.
9. Basco L.K., Le Bras J. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1992, 47:521-527.
10. + exchanger activity and quinine resistance. Mol. Biochem. Parasitol. 2007, 153:48-58.
11. Bertaux L., Kraemer P., Taudon N., Trignol A., Martelloni M., Saidi R., Parzy D., Pradines B., Simon F. Quinine-resistant malaria in traveler returning from French Guiana, 2010. Emerg. Infect. Dis. 2011, 17:943-945.
12. + antiport of Plasmodium falciparum membrane. J. Cell Physiol. 1993, 154:527-534.
13. Brasseur P., Kouamouo J., Moyou-Somo R., Druilhe P. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine- and quinine-resistant isolates in the original foci. Am. J. Trop. Med. Hyg. 1992, 46:1-7.
14. Briolant S., Henry M., Oeuvray C., Amalvict R., Baret E., Didillon E., Rogier C., Pradines B. Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum. Antimicrob. Agents Chemother. 2010, 54:3537-3544.
15. + exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo. Malar. J. 2011, 10:37.
16. Chongsuphajaisiddhi T., Sabchareon A., Attanath P. Treatment of quinine resistant falciparum malaria in Thai children. Southeast Asian J. Trop. Med. Public Health 1983, 14:357-362.
17. + exchanger (pfnhe-1) gene among Indian isolates. Acta Trop. 2009, 109:241-244.
18. de Vries P.J., Bich N.N., Van Thien H., Hung L.N., Anh T.K., Kager P.A., Heisterkamp S.H. Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. Antimicrob. Agents Chemother. 2000, 44:1302-1308.
19. Ferdig M.T., Cooper R.A., Mu J., Deng B., Joy D.A., Su X.Z., Wellems T.E. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 2004, 52:985-997.
20. Gardner M.J., Shallom S.J., Carlton J.M., Salzberg S.L., Nene V., Shoaibi A., Ciecko A., Lynn J., Rizzo M., Weaver B., Jarrahi B., Brenner M., Parvizi B., Tallon L., Moazzez A., Granger D., Fujii C., Hansen C., Pederson J., Feldblyum T., Peterson J., Suh B., Angiuoli S., Pertea M., Allen J., Selengut J., White O., Cummings L.M., Smith H.O., Adams M.D., Venter J.C., Carucci D.J., Hoffman S.L., Fraser C.M. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature 2002, 419:531-534.
21. Goudet J. FSTAT (Version 1.2): a computer program to calculate F-statistics. J. Hered. 1995, 485-486.
22. Hall T. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
23. Hawley S.R., Bray P.G., Mungthin M., Atkinson J.D., O'Neill P.M., Ward S.A. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 1998, 42:682-686.
24. + exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob. Agents Chemother. 2009, 53:1926-1930.
25. McGready R., Brockman A., Cho T., Cho D., van Vugt M., Luxemburger C., Chongsuphajaisiddhi T., White N.J., Nosten F. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:689-693.
26. McGready R., Ashley E.A., Moo E., Cho T., Barends M., Hutagalung R., Looareesuwan S., White N.J., Nosten F. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J. Infect Dis. 2005, 192:846-853.
27. + exchanger. Antimicrob. Agents Chemother. 2010, 54:4306-4313.
28. Mu J., Ferdig M.T., Feng X., Joy D.A., Duan J., Furuya T., Subramanian G., Aravind L., Cooper R.A., Wootton J.C., Xiong M., Su X.Z. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 2003, 49:977-989.
29. Nei M. Estimation of average heterozygosity and genetic distance from a small number of individuals. Genetics 1978, 89:583-590.
30. Nkrumah L.J., Riegelhaupt P.M., Moura P., Johnson D.J., Patel J., Hayton K., Ferdig M.T., Wellems T.E., Akabas M.H., Fidock D.A. Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol. Biochem. Parasitol. 2009, 165:122-131.
31. Okombo J., Kiara S.M., Rono J., Mwai L., Pole L., Ohuma E., Borrmann S., Ochola L.I., Nzila A. In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya. Antimicrob. Agents Chemother. 2010, 54:3302-3307.
32. Okombo J., Ohuma E., Picot S., Nzila A. Update on genetic markers of quinine resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 2011, 177:77-82.
33. + exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum. Antimicrob. Agents Chemother. 2011, 55:5834-5841.
34. + antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc. Natl. Acad. Sci. USA 1984, 81:4833-4837.
35. Poyomtip T., Suwandittakul N., Sitthichot N., Khositnithikul R., Tan-ariya P., Mungthin M. Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum. Malar. J. 2012, 11:7.
36. Pradines B., Pistone T., Ezzedine K., Briolant S., Bertaux L., Receveur M.C., Parzy D., Millet P., Rogier C., Malvy D. Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg. Infect. Dis. 2011, 16:546-548.
37. Price R.N., Uhlemann A.C., Brockman A., McGready R., Ashley E., Phaipun L., Patel R., Laing K., Looareesuwan S., White N.J., Nosten F., Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004, 364:438-447.
38. Pukrittayakamee S., Supanaranond W., Looareesuwan S., Vanijanonta S., White N.J. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:324-327.
39. Pukrittayakamee S., Chantra A., Vanijanonta S., Clemens R., Looareesuwan S., White N.J. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 2000, 44:2395-2398.
40. Putney L.K., Barber D.L. Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition. J. Biol. Chem. 2003, 278:44645-44649.
41. Rahman M.R., Paul D.C., Rashid M., Ghosh A., Bangali A.M., Jalil M.A., Faiz M.A. A randomized controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh - narrowing the options for the National Malaria Control Programme?. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:661-667.
42. Raj D.K., Mu J., Jiang H., Kabat J., Singh S., Sullivan M., Fay M.P., McCutchan T.F., Su X.Z. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J. Biol. Chem. 2009, 284:7687-7696.
43. Saliba K.J., Kirk K. pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a V-type h(+)-ATPase. J. Biol. Chem. 1999, 274:33213-33219.
44. Simon F., Le Bras J., Charmot G., Girard P.M., Faucher C., Pichon F., Clair B. Severe chloroquine-resistant falciparum malaria in Gabon with decreased sensitivity to quinine. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:996-997.
45. Sinou V., Quang le H., Pelleau S., Huong V.N., Huong N.T., Tai le M., Bertaux L., Desbordes M., Latour C., Long L.Q., Thanh N.X., Parzy D. Polymorphism of Plasmodium falciparum Na(+)/H(+) exchanger is indicative of a low in vitro quinine susceptibility in isolates from Vietnam. Malar. J. 2011, 10:164.
46. Spillman N.J., Allen R.J., Kirk K. Acid extrusion from the intraerythrocytic malaria parasite is not via a Na(+)/H(+) exchanger. Mol. Biochem. Parasitol. 2008, 162:96-99.
47. Valderramos S.G., Fidock D.A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 2006, 27:594-601.
48. + exchanger 1 transporter protein implicated in quinine resistance. Antimicrob. Agents Chemother. 2007, 51:4508-4511.
49. Warsame M., Wernsdorfer W.H., Willcox M., Kulane A.A., Bjorkman A. The changing pattern of Plasmodium falciparum susceptibility to chloroquine but not to mefloquine in a mesoendemic area of Somalia. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:200-203.
50. Wellems T.E., Hayton K., Fairhurst R.M. The impact of malaria parasitism: from corpuscles to communities. J. Clin. Invest. 2009, 119:2496-2505.
51. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2002, 2:209-218.
52. Wootton J.C., Feng X., Ferdig M.T., Cooper R.A., Mu J., Baruch D.I., Magill A.J., Su X.Z. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
53. World Health Organization, 2010. Global report on antimalarial efficacy and drug resistance: 2000-2010. <> (accessed 15.06.12). http://whqlibdoc.who.int/publications/2010/9789241500470_eng.pdf.
54. World Health Organization, 2010. Guidelines for the treatment of malaria 2011. <> (accessed 15.06.12). http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf.
55. Wright S. The interpretation of population structure by F-statistics with special regard to systems of mating. Evolution 1965, 19:395-420.